JPRN-jRCTs031230348
Recruiting
未知
Exploratory clinical study on efficacy and safety of hochuekkito for exercise capacity of patients with heart failure in home-based cardiac rehabilitation
Amiya Eisuke0 sites30 target enrollmentSeptember 19, 2023
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Heart failure patients scheduled to undergo home-based cardiac rehabilitation
- Sponsor
- Amiya Eisuke
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Patients performing home\-based cardiac rehabilitation
- •2\) Patients with stage C heart failure staging in ACCF/AHA guidelines
- •3\) Patients who can walk independently
- •4\) Patients aged 18 or older
- •5\) Male or female
- •6\) Patients who can take study drug orally
- •7\) Patients who are able to provide written consent
Exclusion Criteria
- •1\) Patients with biventricular pacemaker placement or after implantation of a ventricular assist device
- •2\) Patients with a history of heart transplantation
- •3\) Patients at risk of severe arrhythmia, including ventricular tachycardia
- •4\) Patients with serum potassium levels less than 3\.0 mEq/L within 12 weeks before enrollment
- •5\) Patients with severe liver or renal disorder
- •6\) Patients with malignant tumors
- •7\) Patients with mental illness who cannot respond to questionnaire surveys
- •8\) Patients who have a history of allergies or side effects (such as pseudo aldosteronism) in kampo (herbal medicine)
- •9\) Patients with a history of serious drug allergy such as anaphylactic shock or a history of serious side effects
- •10\) Patients taking prohibited drugs or study drugs within 2 weeks before consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical study to investigate safety and efficacy on a combined use of rituximab and auto-gamma/delta T cell therapy for CD20-positive B-cell lymphoma.CD20-positive B-cell lymphomaJPRN-UMIN000003641Japanese Red Cross Medical Center15
Completed
Phase 1
Clinical study to investigate safety and efficacy on autologous tumor lysate-pulsed dendritic cellsMalignant GliomaJPRN-UMIN000001903Osaka National Hospital, National Hospital Organization15
Completed
Not Applicable
Clinical study to investigate safety and efficacy on combination of gemcitabine and autologous gamma/delta T cell transfer therapy after resection of pancreatic cancerPancreatic cancerJPRN-UMIN000000931The University of Tokyo Hospital30
Completed
Not Applicable
Exploratory trial to evaluate safety and efficacy of hydroxyapatite film formed by new dental treatment system for caries, dentin hypersensitivity or discolored tooth (investigator-initiated clinical trial)caries, dentin hypersensitivity or discolored toothJPRN-UMIN000015439Tohoku University Graduate School of Dentistry30
Completed
Not Applicable
Exploratory trial to evaluate safety and efficacy of minimally invasive radiofrequency ablation therapy for primary aldosteronism patients (investigator-initiated clinical trial)primary aldosteronism caused by unilateral aldosterone hyper secretionJPRN-UMIN000012792Department of Diagnostic Radiology,Tohoku University Hospital10